Xiao Run Chang
Director/Miembro de la Junta en Beijing Hongcheng Liye Technology Co., Ltd. .
Perfil
Xiao Run Chang currently works at Guodu Securities Co., Ltd., as Independent Director from 2020, XinYu Pharmaceutical Co., Ltd., as Independent Director from 2015, and Beijing Hongcheng Liye Technology Co., Ltd., as Independent Director from 2016.
Dr. Chang also formerly worked at Western Securities Co., Ltd., as Independent Director.
Dr. Chang received his doctorate degree in 2009 from Renmin University of China.
Cargos activos de Xiao Run Chang
Empresas | Cargo | Inicio |
---|---|---|
Beijing Hongcheng Liye Technology Co., Ltd.
Beijing Hongcheng Liye Technology Co., Ltd. Packaged SoftwareTechnology Services Beijing Hongcheng Liye Technology Co., Ltd. provides integrated services including technology platform development, operation, and maintenance. Its services include online higher education, off-campus learning center, adult education, information technology training, and corporate training. The company was founded on May 19, 2003 and is headquartered in Beijing, China. | Director/Miembro de la Junta | 18/12/2016 |
XinYu Pharmaceutical Co., Ltd.
XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Director/Miembro de la Junta | 01/09/2015 |
Guodu Securities Co., Ltd.
Guodu Securities Co., Ltd. Investment Banks/BrokersFinance Guodu Securities Co., Ltd. engages in the provision of capital market services. It offers securities brokerage, securities investment consulting, financial advisors related to trading and securities investment activities, securities underwriting and sponsorship, securities proprietary trading, securities asset management and securities investment fund agency sales. The firm also involves in the intermediary introduction business for future companies; margin financing and securities lending business; agency sales of financial products business; and public offering of securities investment fund management business. The company was founded on December 28, 2001 and is headquartered in Beijing, China. | Director/Miembro de la Junta | 25/12/2020 |
Antiguos cargos conocidos de Xiao Run Chang.
Empresas | Cargo | Fin |
---|---|---|
WESTERN SECURITIES CO.,LTD. | Director/Miembro de la Junta | - |
Formación de Xiao Run Chang.
Renmin University of China | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
WESTERN SECURITIES CO.,LTD. | Finance |
Finance |
Empresas privadas | 2 |
---|---|
Beijing Hongcheng Liye Technology Co., Ltd.
Beijing Hongcheng Liye Technology Co., Ltd. Packaged SoftwareTechnology Services Beijing Hongcheng Liye Technology Co., Ltd. provides integrated services including technology platform development, operation, and maintenance. Its services include online higher education, off-campus learning center, adult education, information technology training, and corporate training. The company was founded on May 19, 2003 and is headquartered in Beijing, China. | Technology Services |
XinYu Pharmaceutical Co., Ltd.
XinYu Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Xinyu Pharmaceutical Co., Ltd. engages in the research, development, and production of microbial pharmaceuticals. Its key products are the active pharmaceutical ingredient lincomycin hydrochlorlde and its derivatives, which include clindamycin hydrochloride and clindamycin phosphate, as well as neomycin sulphate, moxidectin, framycetin sulphate, tenofovir disoproxil fumarate, nosihepitde premix, and enramycin premix. The company was founded in 1988 and is headquartered in Suzhou, China. | Health Technology |
- Bolsa de valores
- Insiders
- Xiao Run Chang